Sherwin-Williams (NYSE:SHW – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Citigroup in a report issued on Wednesday, Marketbeat reports. They presently have a $423.00 target price on the specialty chemicals company’s stock, up from their prior target price of $418.00. Citigroup’s price objective would suggest a potential upside of 19.77% from the company’s previous close.
Several other equities research analysts also recently commented on the company. Mizuho decreased their price objective on Sherwin-Williams from $435.00 to $408.00 and set an “outperform” rating for the company in a report on Tuesday, January 7th. Zelman & Associates upgraded shares of Sherwin-Williams to a “strong-buy” rating in a report on Friday, January 17th. StockNews.com lowered Sherwin-Williams from a “buy” rating to a “hold” rating in a report on Thursday, November 28th. JPMorgan Chase & Co. upped their price target on Sherwin-Williams from $370.00 to $390.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Robert W. Baird set a $370.00 price objective on Sherwin-Williams in a research note on Friday, January 31st. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $400.76.
Read Our Latest Research Report on Sherwin-Williams
Sherwin-Williams Stock Up 2.7 %
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.07 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. During the same period in the prior year, the business earned $1.81 earnings per share. On average, research analysts anticipate that Sherwin-Williams will post 12 earnings per share for the current year.
Institutional Trading of Sherwin-Williams
Institutional investors and hedge funds have recently modified their holdings of the stock. B. Riley Wealth Advisors Inc. boosted its position in Sherwin-Williams by 7.7% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 10,258 shares of the specialty chemicals company’s stock worth $3,487,000 after acquiring an additional 732 shares during the last quarter. Polar Asset Management Partners Inc. boosted its stake in Sherwin-Williams by 347.9% during the fourth quarter. Polar Asset Management Partners Inc. now owns 61,366 shares of the specialty chemicals company’s stock worth $20,860,000 after buying an additional 47,666 shares during the last quarter. American Trust grew its holdings in Sherwin-Williams by 2.1% in the 4th quarter. American Trust now owns 6,866 shares of the specialty chemicals company’s stock valued at $2,334,000 after buying an additional 139 shares in the last quarter. Putney Financial Group LLC purchased a new stake in Sherwin-Williams in the 4th quarter valued at $394,000. Finally, Value Partners Investments Inc. increased its stake in shares of Sherwin-Williams by 4.6% in the 4th quarter. Value Partners Investments Inc. now owns 6,683 shares of the specialty chemicals company’s stock worth $2,270,000 after acquiring an additional 296 shares during the last quarter. Hedge funds and other institutional investors own 77.67% of the company’s stock.
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Stories
- Five stocks we like better than Sherwin-Williams
- Do ETFs Pay Dividends? What You Need to Know
- Stanley Druckenmiller Bets Big on Airline Stocks – Should You?
- Investing In Automotive Stocks
- Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Industry Leading Stocks Just Raised Dividends by 10% or More
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.